Skip to main content

Published locations for Belimumab response at 2 years achieved by two-thirds of lupus patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Belimumab response at 2 years achieved by two-thirds of lupus patients

User login

  • Reset your password
  • /content/belimumab-response-2-years-achieved-two-thirds-lupus-patients
  • /familypracticenews/article/135140/lupus-connective-tissue-diseases/belimumab-response-2-years
  • /internalmedicinenews/article/135140/lupus-connective-tissue-diseases/belimumab-response-2-years
  • /rheumatologynews/article/135140/lupus-connective-tissue-diseases/belimumab-response-2-years-achieved
  • /rheumatology/article/135140/lupus-connective-tissue-diseases/belimumab-response-2-years-achieved-two
  • /internalmedicine/article/135140/lupus-connective-tissue-diseases/belimumab-response-2-years-achieved
  • /familymedicine/article/135140/lupus-connective-tissue-diseases/belimumab-response-2-years-achieved